Removal of KCNQ2 from parvalbumin-expressing interneurons improves anti-seizure efficacy of retigabine.
Exp Neurol
; 355: 114141, 2022 09.
Article
in En
| MEDLINE
| ID: mdl-35691372
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parvalbumins
/
Phenylenediamines
Limits:
Animals
Language:
En
Journal:
Exp Neurol
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
United States